Using paired normal and tumor tissue and immunohistochemical staining, Yi-Chieh reported that TMED9 may be used as a predictive biomarker and potential treatment target (9), which was similar to the other cancer-related genes in other cancer types (10, 11). Here, TMED9 is linked to cancer.